ODYY (Odyssey Group International) Valuation Rank

View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Odyssey Group International Valuation Rank Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Odyssey Group International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102

Website

https://www.odysseyhealthinc.com

Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. The company have two different technologies in the research and development stage; the CardioMap heart monitoring and screening device, and the Save a Life choking rescue device.

Executives

Erik C. Emerson	other: Chief Commercial Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda	other: Chief Operating Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson	director	2372 MORSE AVE., IRVINE CA 92614
Christine Farrell	officer: Controller/Secretary	2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo	director	62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey	director	2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy	director	2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d	director	2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond	director, officer: President/CEO	10 CANTERBURY ROAD, WINDHAM NH 03087